University of Colorado, Denver: Colorectal Neoplasms trials
The registry lists 15 Colorectal Neoplasms studies with University of Colorado, Denver as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 2Phase 2 5Phase 3 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal CancerRecruitingNCT07759921Not applicable
- Increasing CRC Screening in Community Health Centers Through Mobile Messaging OptimizationNot yet recruitingNCT07569250Not applicable
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionRecruitingNCT05517811
- Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal CancerTerminatedNCT05167409Phase 2Results posted
- Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic MetastasesTerminatedNCT04973007Phase 4Results posted
- Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal CancerCompletedNCT03475004Phase 2Results posted
- Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal CancerActive, not recruitingNCT06784947Phase 2
- Couple-Based Mindfulness Intervention for Metastatic Colorectal CancerCompletedNCT05840263
- Second Opinions in OncologyCompletedNCT05102500
- Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal CancerActive, not recruitingNCT04963283Phase 2
- Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal PolypsCompletedNCT04160832
- Anti-PD-1 +/- RT for MSI-H Solid TumorsWithdrawnNCT04001101Phase 2
- Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver MetastasesWithdrawnNCT03802747Phase 1
- Predictors of Physical Activity Maintenance in Colorectal Cancer SurvivorsCompletedNCT03781154Phase 3
- OSI-906 and Irinotecan in Patients With Advanced CancerTerminatedNCT01016860Phase 1